Esteve Quimica Expands Early Phase Capabilities

摘要

Esteve Quimica (EQ), the active phar-maceutical ingredients (APIs) manufacturer owned by drug maker Esteve (Barcelona), says it plans to boost its early phase production capability and increase its presence on the international market by expanding production capacity. EQ says it will build a pilot plant at Celra, Spain with a total reaction capacity of 10 cu meters to boost its early phase capabilities. The plant is due onstream in 2004, and cGMP validation is expected by the end of 2004, says Valerie de Lamer, assistant technical director at EQ.